12 Analysts Assess 10x Genomics: What You Need To Know
12 Analysts Assess 10x Genomics: What You Need To Know
12位分析师评估10x genomics：你需要知道什么
In the preceding three months, 12 analysts have released ratings for 10x Genomics (NASDAQ:TXG), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中，有12名分析师对10x genomics（纳斯达克：TXG）发布了评级，提出了从看好到看淡的各种观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他们最近的评级，展示了过去30天内的情绪演变并与之前的几个月进行了比较。
Analysts have set 12-month price targets for 10x Genomics, revealing an average target of $33.0, a high estimate of $55.00, and a low estimate of $16.00. Observing a downward trend, the current average is 33.02% lower than the prior average price target of $49.27.
分析师已为10x genomics设定了12个月的价值目标，显示平均目标为33.0美元，最高估计为55.00美元，最低估计为16.00美元。当前平均值比之前的平均价值目标49.27美元低了33.02％，呈现下降趋势。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细剖析
In examining recent analyst actions, we gain insights...
通过审查最近的分...
登录免费看全文
登录/注册